PRAGA, LONDRES y CHICAGO, 11 de septiembre de 2025 /PRNewswire/ — Zentiva, una compañía farmacéutica líder de genéricos en Europa, Advent y GTCR, dos inversores líderes mundiales de capital privado, anunciaron hoy la venta de Zentiva por parte de Advent a GTCR. Desde la adquisición de Zentiva de Sanofi en 2018, Advent ha colaborado estrechamente con… Continue reading Zentiva, una compañía farmacéutica líder de genéricos en Europa, anuncia la venta de Advent a GTCR
Tag: Morgan
Chinese EV Firm Nio Raises $1 Billion in Share Sale
The NIO Inc. logo. (Bloomberg) — Nio Inc. raised about $1 billion through a share sale, as the Chinese electric-vehicle maker takes advantage of a recent stock rally to fund its growth. The Shanghai-based EV maker sold about 181.8 million new shares at HK$43.36 ($5.57) the company said in a statement. Nio said it will… Continue reading Chinese EV Firm Nio Raises $1 Billion in Share Sale
@Nio: NIO Inc. Announces Pricing of US$1 Billion Equity Offering000809
SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced the pricing of its US$1 billion offering (the “Equity Offering”) relating to a total of 181,818,190 Class A ordinary shares of the Company,… Continue reading @Nio: NIO Inc. Announces Pricing of US$1 Billion Equity Offering000809
@Nio: NIO Inc. Announces Proposed Equity Offering000808
SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced a proposed offering (the “Equity Offering”) relating to a total of up to 181,818,190 Class A ordinary shares of the Company,… Continue reading @Nio: NIO Inc. Announces Proposed Equity Offering000808
SPX FLOW’s New Brisbane Facility Unlocks More Capacity for Customers
CHARLOTTE, N.C., Sept. 10, 2025 /PRNewswire/ — SPX FLOW’s industrial mixing business, the largest in the world, is proud to announce the relocation of its Queensland operations to a new 2,300 square-metered (sqm) space in Brisbane, Australia. The site represents a significant upgrade from the previous 520 sqm location, greatly enhancing the site’s capacity to serve customers… Continue reading SPX FLOW’s New Brisbane Facility Unlocks More Capacity for Customers
Amazon’s Zoox jumps into U.S. robotaxi race with Las Vegas launch
Five years after its splashy $1.3 billion acquisition of Zoox, Amazon has officially entered the U.S. robotaxi race, which to date has been dominated by Alphabet’s Waymo. Zoox’s first public launch kicks off Wednesday on the Las Vegas strip. The company is offering free rides from a few select locations, with plans to expand more… Continue reading Amazon’s Zoox jumps into U.S. robotaxi race with Las Vegas launch
AMDA College of the Performing Arts Named Among Top Colleges on Playbill’s 2024-2025 Broadway List
NEW YORK, Sept. 10, 2025 /PRNewswire/ — AMDA College of the Performing Arts has once again earned a top spot on Playbill’s annual list of colleges with the most graduates appearing on Broadway. Playbill’s article, “Where Did the Actors of the Broadway Season Go to School?” is published each year with this year’s list looking… Continue reading AMDA College of the Performing Arts Named Among Top Colleges on Playbill’s 2024-2025 Broadway List
Avidity Biosciences Announces Proposed Public Offering of Common Stock
SAN DIEGO, Sept. 10, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that it intends to offer and sell, subject to market and other conditions, $500.0 million of shares of its common stock in an underwritten public… Continue reading Avidity Biosciences Announces Proposed Public Offering of Common Stock
Synopsys downgraded, Oracle upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Oracle (ORCL) to Buy from Neutral with a price target of $410, up from $240, after “an historic… Continue reading Synopsys downgraded, Oracle upgraded: Wall Street’s top analyst calls
Synopsys downgraded, Oracle upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Citi upgraded Oracle (ORCL) to Buy from Neutral with a price target of $410, up from $240, after “an historic… Continue reading Synopsys downgraded, Oracle upgraded: Wall Street’s top analyst calls